{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:58:58Z","timestamp":1780469938817,"version":"3.54.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004096","name":"Kyushu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.pedneo.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:30:38Z","timestamp":1648780238000},"page":"542-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-dose immunoglobulin therapy for steroid-resistant myositis in juvenile localized scleroderma"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0167-3322","authenticated-orcid":false,"given":"Motoshi","family":"Sonoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0735-6566","authenticated-orcid":false,"given":"Masataka","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhide","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouichi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2022.01.006_bib1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/jdv.14197","article-title":"Localized scleroderma: clinical and epidemiological features with emphasis on adulthood- versus childhood-onset disease differences","volume":"31","author":"Lis-\u015awi\u0119ty","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pedneo.2022.01.006_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40257-017-0269-x","article-title":"Morphea and eosinophilic fasciitis: an update","volume":"18","author":"Mertens","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.pedneo.2022.01.006_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10354-017-0595-x","article-title":"Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology","volume":"168","author":"Dourmishev","year":"2018","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.pedneo.2022.01.006_bib4","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3928\/19382359-20161214-01","article-title":"Intravenous immunoglobulin in pediatric rheumatology: when to use it and what is the evidence","volume":"46","author":"Rodriguez","year":"2017","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.pedneo.2022.01.006_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/ced.13352","article-title":"Subcutaneous immunoglobulin for the treatment of deep morphoea in a child","volume":"43","author":"Yamazaki-Nakashimada","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.pedneo.2022.01.006_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3389\/fimmu.2019.00908","article-title":"Immunopathogenesis of pediatric localized scleroderma","volume":"10","author":"Torok","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.pedneo.2022.01.006_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/bjd.17312","article-title":"Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma","volume":"180","author":"Kurzinski","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957222000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957222000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:56:31Z","timestamp":1761749791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957222000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1875957222000638"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2022.01.006","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose immunoglobulin therapy for steroid-resistant myositis in juvenile localized scleroderma","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}